Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.

While at the Lumiere Festival in Lyon where he’s being honored with a career tribute, Michael Mann reflected on his time in ...